Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_assertion type Assertion NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_head.
- NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_assertion description "[Assessment of frequencies of lifestyle factors and polymorphisms of drug-metabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC) patients in a department of surgical medicine--a pilot investigation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_provenance.
- NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_assertion evidence source_evidence_literature NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_provenance.
- NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_assertion SIO_000772 11911601 NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_provenance.
- NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_assertion wasDerivedFrom befree-20140225 NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_provenance.
- NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_assertion wasGeneratedBy ECO_0000203 NP505244.RA63Z0FqLPobG1H_iDAmHg2AFszRSrs6xmLv0M7IZPYcQ130_provenance.